| Analysis | Metabolite Name | Measured Value | Units | Strain | Treatment |
|---|---|---|---|---|---|
| Peak area positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 23800.00 | Peak area | B6.Sle1.Sle2.Sle3 (TC) | lupus prone |
| Peak area positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 415000.00 | Peak area | C57BL/6J | control |
| Peak area positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 433000.00 | Peak area | C57BL/6J | control |
| Peak area positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 646000.00 | Peak area | C57BL/6J | control |
| Peak area positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 683000.00 | Peak area | C57BL/6J | control |
| Peak area positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 767000.00 | Peak area | C57BL/6J | control |
| Peak area positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 851000.00 | Peak area | C57BL/6J | control |
| Peak area positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 890000.00 | Peak area | C57BL/6J | control |
| Peak area positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 1010000.00 | Peak area | B6.Sle1.Sle2.Sle3 (TC) | lupus prone |
| Peak area positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 1050000.00 | Peak area | C57BL/6J | control |
| Peak area positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 1140000.00 | Peak area | B6.Sle1.Sle2.Sle3 (TC) | lupus prone |
| Peak area positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 1160000.00 | Peak area | B6.Sle1.Sle2.Sle3 (TC) | lupus prone |
| Peak area positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 1220000.00 | Peak area | B6.Sle1.Sle2.Sle3 (TC) | lupus prone |
| Peak area positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 1260000.00 | Peak area | B6.Sle1.Sle2.Sle3 (TC) | lupus prone |
| Peak area positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 1330000.00 | Peak area | B6.Sle1.Sle2.Sle3 (TC) | lupus prone |
| Peak area positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 1450000.00 | Peak area | B6.Sle1.Sle2.Sle3 (TC) | lupus prone |
| Peak height positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 162000.00 | Peak height | C57BL/6J | control |
| Peak height positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 168000.00 | Peak height | C57BL/6J | control |
| Peak height positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 184000.00 | Peak height | C57BL/6J | control |
| Peak height positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 202000.00 | Peak height | C57BL/6J | control |
| Peak height positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 226000.00 | Peak height | C57BL/6J | control |
| Peak height positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 230000.00 | Peak height | C57BL/6J | control |
| Peak height positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 237000.00 | Peak height | C57BL/6J | control |
| Peak height positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 247000.00 | Peak height | C57BL/6J | control |
| Peak height positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 301000.00 | Peak height | B6.Sle1.Sle2.Sle3 (TC) | lupus prone |
| Peak height positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 321000.00 | Peak height | B6.Sle1.Sle2.Sle3 (TC) | lupus prone |
| Peak height positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 331000.00 | Peak height | B6.Sle1.Sle2.Sle3 (TC) | lupus prone |
| Peak height positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 351000.00 | Peak height | B6.Sle1.Sle2.Sle3 (TC) | lupus prone |
| Peak height positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 370000.00 | Peak height | B6.Sle1.Sle2.Sle3 (TC) | lupus prone |
| Peak height positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 381000.00 | Peak height | B6.Sle1.Sle2.Sle3 (TC) | lupus prone |
| Peak height positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 396000.00 | Peak height | B6.Sle1.Sle2.Sle3 (TC) | lupus prone |
| Peak height positive ion mode | 1-(8-[3]-ladderane-octanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphocholine | 405000.00 | Peak height | B6.Sle1.Sle2.Sle3 (TC) | lupus prone |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|